AF
LEGN icon

Allworth Financial’s Legend Biotech LEGN Stock Holding History

Allworth Financial’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Buy
382
+266
+229% +$7.17K ﹤0.01% 3650
2026
Q1 		$2.1K Sell
116
-7
-6% -$133 ﹤0.01% 4339
2025
Q4 		$2.67K Sell
123
-161
-57% -$4.61K ﹤0.01% 4008
2025
Q3 		$9.26K Buy
284
+25
+10% +$923 ﹤0.01% 3183
2025
Q2 		$9.19K Buy
259
+216
+502% +$7K ﹤0.01% 2933
2025
Q1 		$1.47K Sell
43
-37
-46% -$1.33K ﹤0.01% 3325
2024
Q4 		$3K Buy
+80
New +$3.31K ﹤0.01% 2993

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Allworth Financial's LEGN Position: Q2 2026 in Review

Allworth Financial increased its Legend Biotech (LEGN) stake by 229% in Q2 2026, buying an estimated $7.17K and bringing the position to 382 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #3650.

Allworth Financial first reported a position in LEGN in Q4 2024 and has held it in 7 quarters since. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Allworth Financial held 382 shares of Legend Biotech worth $11K as of Q2 2026.
  • Allworth Financial bought 266 Legend Biotech shares in Q2 2026, an estimated $7.17K.
  • Legend Biotech made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3650 holding.
  • Allworth Financial first reported a position in Legend Biotech in Q4 2024 and has held it in 7 quarters since.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.